Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra
- 23 May 1994
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 173 (1-2) , 1-4
- https://doi.org/10.1016/0304-3940(94)90136-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Regulation of the Chromaffin Granule Catecholamine Transporter in Cultured Bovine Adrenal Medullary Cells: Stimulus–Biosynthesis CouplingJournal of Neurochemistry, 1992
- D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatmentBrain Research, 1992
- Effects of chronic treatment with selective agonists on the subtypes of dopamine receptorsBrain Research, 1992
- Attenuation of pulsatile changes in the density of striatal [3H]GBR-12935 binding sites during chronic ethanol consumptionBrain Research, 1991
- Postnatal development of the monoamine vesicular transporter in mesencephalic and telencephalic regions of the rat brain: A quantitative autoradiographic study with [3H]dihydrotetrabenazineNeuroscience Letters, 1990
- Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrierEuropean Journal of Pharmacology, 1989
- The regionalization of [3H]dihydrotetrabenazine binding sites in the mouse brain and its relationship to the distribution of monoamines and their metabolitesBrain Research, 1986
- Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compactaBrain Research, 1986
- On the Significance of Endogenous 3‐Methoxytyramine for the Effects of Centrally Acting Drugs on Dopamine Release in the Rat BrainJournal of Neurochemistry, 1982
- Dopaminergic neurons—Alteration in the sensitivity of tyrosine hydroxylase to inhibition by endogenous dopamine after cessation of impulse flowBiochemical Pharmacology, 1976